Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adverum Biotechnologies Inc. (ADVM)

14.845   -0.905 (-5.75%) 02-21 16:00
Open: 15.7 Pre. Close: 15.75
High: 15.7 Low: 14.68
Volume: 1,312,868 Market Cap: 959M
Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.733 - 15.828 15.828 - 15.898
Low: 14.464 - 14.584 14.584 - 14.673
Close: 14.692 - 14.87 14.87 - 15.001

Technical analysis

as of: 2020-02-21 4:27:27 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 19.63     One year: 22.93
Support: Support1: 12.46    Support2: 9.77
Resistance: Resistance1: 16.81    Resistance2: 19.63
Pivot: 13.22
Moving Average: MA(5): 15.78     MA(20): 12.64
MA(100): 9.93     MA(250): 9.40
MACD: MACD(12,26): 1.27     Signal(9): 0.90
Stochastic oscillator: %K(14,3): 82.73     %D(3): 89.00
RSI: RSI(14): 63.34
52-week: High: 16.81  Low: 4.01  Change(%): 245.2
Average Vol(K): 3-Month: 137109  10-Days: 293247

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ADVM has closed below upper band by 33.5%. Bollinger Bands are 270.9% wider than normal. The large width of the bands suggest high volatility as compared to ADVM's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Wed, 19 Feb 2020 20:07:34 +0000
Wednesday 2/19 Insider Buying Report: NEE, ADVM

Mon, 10 Feb 2020 16:27:00 +0000
Here's Why Adverum Biotechnologies Is Soaring Today

Sun, 05 Jan 2020 16:51:00 +0000
Why Your 2020 Resolution Should Be to Buy More Small-Cap Stocks

Sun, 15 Dec 2019 15:00:00 +0000
Validea's Top Five Healthcare Stocks Based On Motley Fool - 12/15/2019

Mon, 02 Dec 2019 12:31:00 +0000
3 Soaring Biotech Stocks to Watch in December

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 64.59
Shares Float (M) 43.35
% Held by Insiders 3.56
% Held by Institutions 85.53
Shares Short (K) 7260
Shares Short P. Month (K)

Stock Financials

EPS -0.960
Book Value (p.s.) 2.540
PEG Ratio
Profit Margin
Operating Margin -18703.44
Return on Assets (ttm) -17.3
Return on Equity (ttm) -32.2
Qtrly Rev. Growth -70.0
Gross Profit (p.s.) -0.751
Sales Per Share
EBITDA (p.s.) -0.902
Qtrly Earnings Growth
Operating Cash Flow (M) -47.06
Levered Free Cash Flow (M) -34.67

Stock Valuations

P/E -15.46
P/E Growth Ratio -0.06
P/BV 5.84
P/CF -20.37

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.